News regarding NextCell Pharma.

 

NextCell is pleased to announce that it has  been to participate in the EIT Health Start.Smart.Global (SSG) programme. EIT Health is a Knowledge and Innovation Community established by the European Institute for Innovation & Technology (EIT), an independent EU body set up to promote innovation and entrepreneurship across Europe. The EIT Health Start.Smart.Global (SSG) programme, helps European life science SMEs optimise their market entries into the lucrative but challenging business environments of Japan and South Korea. NextCell, will receive expert advice on how to potentially enter the Japanese and Korean markets, either for
product commercialization or for further research & development projects. The preparation phase includes on-site training and various e-learning measures throughout the year.

More information regarding the EIT Health Start.Smart.Global (SSG) programme can be found here:
https://www.bio-m.org/en/about-biom/projects/startsmartglobal.html

Press Releases


NextCell och dess aktiviteter stöds av EIT (Health), ett EU-organ

 

Contact Karolinska Institutet Science Park Hälsovägen 7, 141 57 Huddinge info@nextcellpharma.com +46 (0)8 735 55 95